| |
| |
|
| Insider
Information: |
Peltz Stuart Walter |
| Relationship: |
Director |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
189,223 |
|
|
Indirect Shares
|
54,903 |
|
|
| Direct
Value |
$5,736,811 |
|
|
|
Indirect Value
|
$1,845,839 |
|
|
| Total
Shares |
244,126 |
|
|
| Total
Value |
$7,582,650 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -511.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2023-01-31 |
166,962 |
2023-01-31 |
54,903 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-31 |
4 |
S |
$45.63 |
$13,734 |
I/I |
(301) |
54,903 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-31 |
4 |
S |
$45.63 |
$105,857 |
D/D |
(2,320) |
166,962 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-24 |
4 |
S |
$47.45 |
$13,476 |
I/I |
(284) |
55,204 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-11 |
4 |
S |
$44.36 |
$21,825 |
I/I |
(492) |
55,488 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-11 |
4 |
S |
$44.36 |
$52,744 |
D/D |
(1,189) |
169,282 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-10 |
4 |
S |
$42.93 |
$52,722 |
D/D |
(1,228) |
170,471 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-10 |
4 |
S |
$42.93 |
$24,515 |
I/I |
(571) |
55,980 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-09 |
4 |
S |
$41.66 |
$11,622 |
I/I |
(279) |
56,551 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-09 |
4 |
S |
$41.66 |
$74,398 |
D/D |
(1,786) |
171,699 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
53,000 |
173,485 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
18,000 |
56,830 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-02-01 |
4 |
S |
$40.00 |
$11,281 |
I/I |
(282) |
38,728 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-02-01 |
4 |
S |
$40.00 |
$78,444 |
D/D |
(1,961) |
120,485 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-25 |
4 |
S |
$39.31 |
$12,974 |
I/I |
(330) |
39,010 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
I/I |
16,800 |
39,340 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
S |
$38.53 |
$11,326 |
I/I |
(294) |
22,540 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
44,000 |
122,446 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
S |
$38.53 |
$72,003 |
D/D |
(1,869) |
78,446 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-04 |
4 |
S |
$41.16 |
$15,559 |
I/I |
(378) |
22,834 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
I/I |
6,240 |
22,721 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,400 |
16,481 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
S |
$56.96 |
$16,119 |
I/I |
(283) |
15,081 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
S |
$56.96 |
$112,089 |
D/D |
(1,968) |
80,315 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-01-25 |
4 |
S |
$62.05 |
$21,719 |
I/I |
(350) |
15,364 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
I/I |
3,960 |
15,714 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
